Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRVI | ABT | MDT | SYK | BSX |
| Company | Maravai Lifesciences Holdings Inc Cl A | Abbott Laboratories | Medtronic Inc | Stryker Corp | Boston Scientific Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 15.45 | 111.28 | 85.80 | 276.44 | 47.65 |
| High | 15.68 | 112.37 | 87.85 | 282.56 | 48.19 |
| Low | 15.16 | 110.89 | 85.71 | 276.03 | 47.10 |
| Last | 15.50 | 112.25 | 87.58 | 282.48 | 48.07 |
| Change | +0.36 | +0.43 | +1.81 | +3.53 | +0.53 |
| % Change | +2.38% | +0.38% | +2.11% | +1.27% | +1.11% |
| Volume | 1,084,900 | 5,051,400 | 6,940,100 | 2,020,400 | 12,434,900 |
| 20-Day Average Volume | 1,422,065 | 5,189,180 | 6,938,570 | 1,572,915 | 7,883,460 |
| Previous Close | 15.14 | 111.82 | 85.77 | 278.95 | 47.54 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.03 | 111.98 | 81.30 | 258.07 | 46.14 |
| 20-Day Raw Stochastic | 94.88% | 49.56% | 97.40% | 99.77% | 96.88% |
| 20-Day Relative Strength | 58.69% | 55.87% | 65.91% | 69.72% | 63.60% |
| Weighted Alpha | -48.36 | -7.56 | -11.90 | +24.72 | +18.68 |
| Today's Opinion | 48% Sell | 80% Buy | 8% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 64% Buy | 8% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.59% since 01/26/23 | +1.06% since 01/26/23 | +7.01% since 01/26/23 | +11.91% since 01/26/23 | +3.71% since 01/26/23 |
| Low | 13.73 on 01/27/23 | 108.87 on 01/31/23 | 80.81 on 01/27/23 | 248.96 on 01/31/23 | 45.57 on 01/31/23 |
| High | 15.68 on 02/02/23 | 112.37 on 02/02/23 | 87.85 on 02/02/23 | 282.56 on 02/02/23 | 48.19 on 02/02/23 |
| 1-Month | |||||
| %Chg | +8.32% since 12/30/22 | +2.24% since 12/30/22 | +12.69% since 12/30/22 | +15.54% since 12/30/22 | +3.89% since 12/30/22 |
| Low | 12.26 on 01/05/23 | 108.75 on 01/03/23 | 77.38 on 01/03/23 | 243.79 on 01/03/23 | 44.35 on 01/11/23 |
| High | 15.68 on 02/02/23 | 115.69 on 01/11/23 | 87.85 on 02/02/23 | 282.56 on 02/02/23 | 48.19 on 02/02/23 |
| 3-Month | |||||
| %Chg | +0.91% since 11/02/22 | +14.49% since 11/02/22 | +2.10% since 11/02/22 | +33.26% since 11/02/22 | +14.64% since 11/02/22 |
| Low | 12.16 on 12/08/22 | 95.35 on 11/03/22 | 75.76 on 12/16/22 | 205.43 on 11/03/22 | 40.93 on 11/03/22 |
| High | 16.06 on 11/11/22 | 115.69 on 01/11/23 | 87.85 on 02/02/23 | 282.56 on 02/02/23 | 48.19 on 02/02/23 |
| 6-Month | |||||
| %Chg | -39.71% since 08/02/22 | +3.32% since 08/02/22 | -6.04% since 08/02/22 | +32.46% since 08/02/22 | +15.94% since 08/02/22 |
| Low | 12.16 on 12/08/22 | 93.25 on 10/21/22 | 75.76 on 12/16/22 | 200.80 on 09/27/22 | 37.74 on 09/27/22 |
| High | 27.82 on 08/11/22 | 115.69 on 01/11/23 | 95.60 on 08/19/22 | 282.56 on 02/02/23 | 48.19 on 02/02/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,863,834 | 194,966,432 | 114,089,536 | 105,563,048 | 68,092,072 |
| Shares Outstanding, K | 255,207 | 1,743,574 | 1,330,180 | 378,430 | 1,432,311 |
| Annual Sales | 799,240,000 | 43,653,000,000 | 31,686,000,000 | 17,108,000,000 | 11,888,000,000 |
| Annual Net Income | 182,040,000 | 6,933,000,000 | 5,040,000,000 | 1,994,000,000 | 1,041,000,000 |
| Last Quarter Sales | 191,260,000 | 10,091,000,000 | 7,585,000,000 | 4,479,000,000 | 3,170,000,000 |
| Last Quarter Net Income | 44,470,000 | 1,033,000,000 | 427,000,000 | 816,000,000 | 188,000,000 |
| 60-Month Beta | -0.22 | 0.67 | 0.72 | 0.93 | 0.79 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.37 on 11/02/22 | 1.03 on 01/25/23 | 1.30 on 11/22/22 | 3.00 on 01/31/23 | 0.45 on 02/01/23 |
| Latest Earnings Date | 02/22/23 | 01/25/23 | 02/21/23 | 01/31/23 | 02/01/23 |
| Most Recent Dividend | N/A | 0.510 on 01/12/23 | 0.680 on 12/20/22 | 0.750 on 12/29/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/12/23 | 12/20/22 | 12/29/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 7.72 | 20.70 | 15.73 | 27.17 | 27.05 |
